Contemporary HIV Treatment and Prevention 2022

In this engaging meeting series available throughout the United States, expert faculty review key data informing the optimal use of contemporary HIV treatment and prevention. Full details of the many available topics are provided below.

To Host an Event
You know best what educational topic(s) would be most valuable in your local area, so let us know and we can arrange the details. We will work with you to choose the topic, date/time, and speaker. On the day, you will introduce the speaker and help lead the discussion. There will be no cost to the host or the attendees.

Please contact us at meetings@clinicaloptions.com to learn more.

Agenda

Specific meetings can focus on any of the following aspects of the management of ART:

  • Innovations in First-line ART for Diverse Patients
  • State-of-the-Art Switch Strategies in Virologically Suppressed Patients
  • Optimizing HIV Outcomes in Challenging Scenarios
  • Cutting-Edge Concepts in HIV Care
  • Expanding PrEP Uptake: Barriers and Solutions
  • CROI 2022 Update: What Did We Learn?
  • AIDS 2022 Update: What Did We Learn?

The timing and agenda for each individual meeting is as follows:

  • Welcome, CME information, and baseline outcomes questions (10 mins)
  • Case 1 discussion followed by didactic slides (10-15 mins)
  • Case 2 discussion followed by didactic slides (10-15 mins)
  • Case 3 discussion followed by didactic slides (10-15 mins)
  • Question and answer session, concluding outcomes questions (15-20 mins)

Events

Date / Time
Event Details

Faculty

Program Director
Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN

Professor
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Faculty
Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Chair,
Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, Florida

Faculty
Roger Bedimo, MD, MS, FACP

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Michelle S. Cespedes, MD, MS

Associate Professor of Medicine Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York City, NY

Faculty
Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty
Ian Frank, MD

Professor of Medicine
University of Pennsylvania
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Philadelphia, Pennsylvania

Faculty
Jason Halperin, MD, MPH

Assistant Professor of Medicine
Department of Infectious Diseases
Tulane University
Infectious Disease Physician
CrescentCare
New Orleans, Louisiana

Faculty
W. David Hardy, MD

Scientific and Medical Consultant
Adjunct Clinical Professor of Medicine

Division of Infectious Diseases
Keck School of Medicine of USC
Los Angeles, California

Faculty
Gregory Huhn, MD

Associate Professor
Department of Infectious Diseases
Rush University Medical Center
Attending Physician
Department of Infectious Diseases
Cook County Health
Chicago, Illinois

Faculty
Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, 
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Faculty
Paul E. Sax, MD

Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Faculty
Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, 
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Faculty
Marc A. Tribble, MD

Clinical Assistant Professor
Division of Infectious Diseases
Baylor University Medical Center at Dallas
Dallas, Texas

Faculty
Timothy J. Wilkin, MD, MPH

Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York

Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Infectious Diseases
Clinical Trials Unit
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Faculty
Darcy Wooten, MD

Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
  • Identify barriers to PrEP uptake and employ practical strategies to increase PrEP use among those for whom it is recommended
  • Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UAN will be specific to each topic.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.